FDA Hears 80 Speakers on Psychedelic Drug Therapy Standards
The FDA held a public hearing on psychedelic drug therapy, drawing more than 1,800 registered attendees and 80 speakers...
Psychedelics
The FDA’s Psychedelic Guidance Is Really a Study-Design Reckoning
The FDA's July 2026 psychedelic guidance is nonbinding on paper. In practice it tells psilocybin, LSD, and MDMA developers...
How LLMs Can Audit LSD Clinical Trial Ratings in Real Time
MindMed is running three phase three trials of pharmaceutically optimized LSD with a two-person AI team and a custom...
Psychedelics: A Beacon of Hope for Mental Health
The 2023 CNS Summit hosted a pivotal session that illuminated the evolving landscape of clinical trials and drug development...